immunotherapy

Cancer experts have been exploring and improving multiple myeloma treatments that can extend periods of remission and enhance quality of life.

A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.  

Adding mRNA therapy improves the response to cancer immunotherapy in people who weren't responding to the treatment, Mayo Clinic research shows.

A study by Mayo Clinic researchers finds that immune checkpoint inhibitors may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis.

Keith L. Knutson, Ph.D., an immunologist at Mayo Clinic's campus in Florida and a professor in the Mayo Clinic College of Medicine and Science, discusses his research on the immunology and immunotherapy of breast cancer and ovarian cancer.